
Precision Proton Therapy for Thymoma
Yanyan (pseudonym), not yet thirty years old, had once believed that completing her treatment would allow her to leave the shadow of cancer behind and return to an ordinary life. However, a year later, that hope was shattered by the suspected recurrence of the disease in the form of pleural metastasis.
During a routine check-up, a mass measuring approximately 4 cm in diameter was discovered in Yanyan’s anterior-superior mediastinum. Post-surgical pathology identified it as a high-grade Type B3 thymoma—an aggressive subtype of thymic epithelial tumor—with a Ki-67 proliferation index of 60%, indicating highly active tumor cells. Despite completing 27 sessions of adjuvant radiotherapy, fate dealt another blow: less than a year later, a PET-CT scan revealed metastasis in the left lower dorsal pleura.
Faced with this recurrence and after extensive consultation, Yanyan chose to seek cutting-edge proton therapy at Guangzhou Taihe Cancer Hospital. Adhering to the principles of precision medicine and respecting the patient’s wishes, the medical team devised a personalized “Whac-A-Mole” strategy; through meticulous imaging analysis, they also identified a hidden lesion that had previously gone undetected. The treatment course involved 30 sessions with five adaptive plan adjustments, utilizing respiratory gating technology to achieve sub-millimeter precision in targeting the tumor.
The final outcome exceeded expectations: the tumor lesions regressed almost completely, and the patient experienced no significant treatment-related adverse effects throughout the process. “After a period of recuperation, she can happily prepare for her wedding and look stunning in her wedding dress,” said Dr. Lu Hui from the Department of Radiation Oncology at Guangzhou Taihe Cancer Hospital with satisfaction.
“Rooting out” hidden lesions with precision—like a game of “Whac-A-Mole.”
The thymus is located in the upper anterior mediastinum, posterior to the manubrium sterni, in close proximity to vital structures such as the heart, major blood vessels, and both lungs. This unique anatomical positioning necessitates a strong emphasis on protecting normal tissues during radiotherapy; proton therapy, with its sub-millimeter precision, has emerged as an ideal choice for treating tumors in such challenging locations near critical functional areas.
According to the *NCCN Clinical Practice Guidelines for Thymoma and Thymic Carcinoma*, compared to conventional radiotherapy, proton therapy not only significantly improves dose distribution within the target area but also effectively reduces the radiation dose delivered to critical organs—such as the heart, lungs, and spinal cord—thereby ensuring excellent local control rates while substantially minimizing treatment-related toxicity.
In the case of the patient Yanyan, proton therapy reduced the mean radiation dose to her heart by more than 70% compared to conventional radiotherapy. Lung V5 and V30 values (key parameters for assessing radiation exposure to normal tissue) decreased by 12% and 6%, respectively. These results demonstrate the superiority of proton therapy in protecting normal lung tissue, significantly lowering the risk of complications like radiation pneumonitis and enhancing both the safety and precision of the treatment.
Pre-treatment imaging revealed thickening of the left pleura in Yanyan, with multiple nodules and masses visible on the costal and diaphragmatic pleura; the largest lesion measured 2.4 × 6.4 cm.
Dr. Lu Hui noted that the team had considered whole-pleura irradiation, which theoretically offers a more thorough eradication of potential lesions. However, assessments revealed that due to her history of prior radiotherapy, her lung and heart tissues had low radiation tolerance; a whole-pleura approach would have significantly increased the risk of radiation pneumonitis. Furthermore, the patient expressed a clear desire to have children in the future; she hoped to avoid repeated rounds of anti-tumor therapy—provided the disease remained under control—to preserve a window of opportunity for future fertility.
Following a comprehensive evaluation by a multidisciplinary team of experts, the Proton Center devised a personalized “Whac-A-Mole” treatment plan, targeting only the lesions visible on imaging. This strategy aims to enhance local control rates while maximizing the protection of normal tissues. To address the characteristic tendency of thymomas to grow insidiously along the pleura, the team combined MRI with standard CT imaging to more accurately define the tumor’s extent. Leveraging its superior soft-tissue resolution, MRI successfully detected occult lesions that had been missed by CT. These critical findings ensured that high-risk areas—which might otherwise have been overlooked—were included in the radiation field, enabling more precise target delineation and significantly reducing the risk of tumor recurrence.
Furthermore, a longitudinal comparison of imaging data from the previous two years revealed two previously unreported occult lesions: suspicious, slowly enlarging growths in the internal mammary region and above the diaphragm. These lesions were subsequently included in the radiation target volume. Follow-up monitoring confirmed the validity of this decision, as both lesions shrank significantly as radiotherapy progressed.
Five-fraction adaptive planning combined with respiratory gating to dynamically optimize the radiotherapy regimen.
Guangzhou Taihe Cancer Hospital is the first specialized tertiary cancer hospital in South China to be equipped with the world-leading Varian ProBeam proton therapy system. The Proton Center strictly adheres to the radiotherapy guidelines and standard operating procedures of MD Anderson Cancer Center, providing patients with scientifically grounded radiotherapy regimens.
Centered on a philosophy of precision treatment, the Proton Center achieves accurate radiotherapy through the synergy of multi-dimensional technologies. In the case of the patient Yanyan, the lesion distribution was unique: it spanned approximately 20 cm, involving both the apical pleura and the diaphragmatic pleura. Had a single radiotherapy plan been used, respiratory motion would have caused relative displacement between the upper and lower sections of the lesion, compromising irradiation accuracy. To address this, the team innovatively split the treatment into two separate plans—one for the upper lesion and one for the lower. This design effectively resolved the displacement issue, ensured more precise dose distribution, and prevented “geographic miss” (irradiation failure) in the apical and diaphragmatic pleural regions caused by varying amplitudes of respiratory motion.
Furthermore, the team utilized a respiratory gating system (RPM) to mitigate the impact of respiratory motion on tumor positioning. This system captures the patient’s breathing rate and amplitude in real-time, delivering radiation only during specific phases of the respiratory cycle. This “smart targeting” system enhances both treatment precision and patient comfort, eliminating the discomfort associated with traditional breath-holding requirements.
Imagine using a smartphone to navigate to a destination, only to rely on a map that is two days old—sudden road construction appears, yet the navigation system remains unaware. Traditional radiotherapy faces a similar dilemma: plans formulated prior to treatment cannot adapt in real-time to anatomical changes—such as tumor shrinkage or displacement—that occur during the course of therapy. This can lead to dose deviations and increase the risk of radiation-induced damage to critical organs.
In this case, the radiotherapy team monitored tumor regression in real-time. Over the course of 30 proton therapy sessions, they tailored five adaptive plans, making timely adjustments to the target area and optimizing dose distribution to avoid missing the tumor or overdosing healthy tissue.
It is through countless instances of persistence and refinement regarding the details that truly excellent outcomes are achieved. As Director Yuan Taize of the Department of Radiation Oncology emphasized: “The technical demands of precision radiotherapy pose a formidable challenge to the team, requiring physicians, medical physicists, and therapists to invest even greater professional effort and dedication. Yet, whenever a course of action benefits patient treatment, we must spare no effort and attend to every detail with the utmost care; this is work of great significance.”
Leave a reply